Results 141 to 150 of about 16,167 (200)

Treatment Patterns, Adverse Events, and Clinical Outcomes with Steroidal Mineralocorticoid Receptor Antagonists: A Retrospective Analysis of Administrative Claims Data (RELICS). [PDF]

Pragmat Obs Res
Richard EL, Desai NR, Willey VJ, Gay A, Scott C, Folkerts K, Pessina E, Singh R, Teng CC, Oberprieler NG.   +9 more
europepmc   +1 more source

Additional file 1: of Efficacy and safety of mineralocorticoid receptor antagonists for patients with heart failure and diabetes mellitus: a systematic review and meta-analysis

, 2016
Mengdie Chen, Sisi Dong, Ningyu Cai, Meng Fan, Suping Gu, Jin-Jue Zheng, Haimin Yin, Xinhe Zhou, Liang-Xue Wang, Chunying Li, Chao Zheng   +10 more
openalex   +2 more sources

Efficacy of Mineralocorticoid Receptor Antagonists on Kidney and Cardiovascular Outcomes in Patients With Chronic Kidney Disease: An Umbrella Review. [PDF]

Kidney Med
Amornritvanich P, Anothaisintawee T, Attia J, McKay GJ, Thakkinstian A.   +4 more
europepmc   +1 more source

Recent Advances and Perspectives on the Use of Mineralocorticoid Receptor Antagonists for the Treatment of Hypertension and Chronic Kidney Disease: A Review. [PDF]

Biomedicines
Miyasako K, Maeoka Y, Masaki T.
europepmc   +1 more source

Clinical Properties and Non-Clinical Testing of Mineralocorticoid Receptor Antagonists in In Vitro Cell Models. [PDF]

Int J Mol Sci
Varda L, Ekart R, Lainscak M, Maver U, Bevc S.   +4 more
europepmc   +1 more source

Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease: Clinical Evidence and Potential Adverse Events. [PDF]

Clin Diabetes
Upadhyay A, Haider L.
europepmc   +1 more source

Effectiveness and safety of mineralocorticoid receptor antagonists in heart failure patients with and without diabetes: a systematic review and meta-analysis. [PDF]

Egypt Heart J
Adji AS, Widjaja JS, de Liyis BG.
europepmc   +1 more source

Targeting Diabetic Atherosclerosis: The Role of GLP-1 Receptor Agonists, SGLT2 Inhibitors, and Nonsteroidal Mineralocorticoid Receptor Antagonists in Vascular Protection and Disease Modulation. [PDF]

Biomedicines
Rroji M, Spahia N, Figurek A, Spasovski G.   +3 more
europepmc   +1 more source

Comparative analysis of mineralocorticoid receptor antagonists and renin-angiotensin system inhibitors/angiotensin receptor neprilysin inhibitor in heart failure with mildly reduced ejection fraction. [PDF]

Front Pharmacol
Lee CC, Te-Wei Kuan D, Chang KC, Chen ZW, Cheng JF, Lin TT, Lin LY, Wu CK.   +7 more
europepmc   +1 more source

Exploring the Efficacy of Triple Therapy with SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Mineralocorticoid Receptor Antagonists on Cardiovascular and Renal Outcomes in Advanced Heart Failure: A Meta-analysis

Bassem Ashraf
openalex   +2 more sources